Hero Image

Bristol-Myers Squibb to Acquire Celgene

Open Letter to Stockholders

Open Letter to Stockholders

Read Bristol-Myers Squibb’s Board of Directors’ Letter to the company stockholders regarding the value of the planned acquisition of Celgene.

Building Toward a Translational Future

Building Toward a Translational Future

Saurabh Saha leads the translational medicine team and returns to the Boston-area to build out the new R&D facility in Cambridge.

Information on the Bristol-Myers Squibb and Celgene Transaction

Information on the Bristol-Myers Squibb and Celgene Transaction

Learn more about Bristol-Myers Squibb’s planned acquisition of Celgene.

Scientists on the Move

Scientists on the Move

As an R&D footprint expands, several colleagues saw an opportunity to explore new areas of science.  


News & Perspectives

Christoph Koenen, Head of Cardiovascular Development

How Real-world Data is Changing the Landscape 

People

Living Life to the Fullest 

Our R&D Team

Meet Michaela Bowden

Meet Michaela Bowden

Director, Translational Biology

Looking for Answers?

Quick links to helpful resources.

Clinical Trial Information for Researchers

Clinical trials and research are a critical part of bringing new medicines to patients.

Medical Information for Healthcare Providers

Information and resources to assist with caring for patients.

Help Paying for Your Medicines

If you are a patient in the U.S. struggling to understand your coverage or pay for your medication, we may be able to help.